Invention Grant
US07790719B2 Modulators of melanocortin receptor 失效
黑皮质素受体的调节剂

Modulators of melanocortin receptor
Abstract:
This invention provides compounds and methods for treating melanocortin receptor associated disorders, such as weight loss disorders including cachexia resulting from cancer and other chronic illnesses. The compounds are represented by formula I: wherein X is oxygen or sulfur; G is G1 or G2: L1, L2, L3 and Q are linker groups, and Rings A, B and C, and R1-R14 are described in the specification. The compounds are antagonists of melanocortin receptors.
Public/Granted literature
Information query
Patent Agency Ranking
0/0